Meeting
2016 ASCO Annual Meeting
Correlation of circulating tumor cells (CTCs) with peripheral blood leukocytes to predict outcome in metastatic breast cancer (MBC).
Authors
Ugo De Giorgi
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
Ugo De Giorgi , Michal Mego , Emanuela Scarpi , Antonio Giordano , Mario Giuliano , Vicente Valero , Ricardo H. Alvarez , Naoto T. Ueno , Massimo Cristofanilli , James M. Reuben
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11532)
DOI
10.1200/JCO.2016.34.15_suppl.11532
Abstract #
11532
Poster Bd #
229
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Integration of lymphocyte ratios (LRs) and circulating tumor cells (CTCs) characterization: The interplay between immunity and metastatic breast cancer (MBC).
First Author: Lorenzo Gerratana
Poster
2018 Gastrointestinal Cancers Symposium
Association of preoperative monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with overall survival after resection of pancreatic neuroendocrine tumors.
First Author: Roheena Z. Panni
Poster
2023 ASCO Annual Meeting
Prognostic value of tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer (BC): A focus on inflammatory BC.
First Author: Eleonora Nicolò
Poster
2023 ASCO Annual Meeting
Validation of a single-cell sequencing assay for the detection of circulating tumor cells in metastatic breast cancer.
First Author: David Bourdon